HR020602

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HR020602, covering 2024-03-04 to 2024-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics, Safety and Efficacy of HR020602 Injection in Children Undergoing General Anesthesia [Phase 2]